M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (free registration required)

Related:

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.